Brufen

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Brufen

Quick Facts

Property Description
Active Ingredient Ibuprofen
Pharmacological Class Non-Steroidal Anti-Inflammatory Drug (NSAID)
Common Use Pain relief, fever reduction, inflammation
Origin Synthetic (chemically derived)
Primary Forms Tablet, capsule, oral suspension

What Type of Medicine Is Brufen? (Identity and Classification)

Brufen is a widely recognized trade name for a medicinal entity containing the active ingredient Ibuprofen, a compound explicitly classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID). This synthetic substance belongs specifically to the propionic acid derivative chemical sub-class. Its classification confirms its three-fold role: it functions as an analgesic for pain relief, an antipyretic for fever reduction, and, uniquely for its type, an agent that actively reduces inflammation. Ibuprofen is recognized for its clinical utility, including its inclusion on essential medicines lists.


Composition and Available Forms (Substance and Presentation)

The core therapeutic component is Ibuprofen, which is typically manufactured and administered as a racemic mixture of two molecular forms, S- and R-enantiomers. This means the product is a single active ingredient product, but the S-enantiomer is primarily responsible for the clinical activity. This medicine is intended for oral intake, utilizing diverse dosage forms such as the traditional tablet and film-coated tablet, capsule, alongside liquid formulations like the oral suspension and concentrated drops. The variety of dosage forms supports suitability for use across different patient groups, including children.


What Is Brufen's General Purpose? (Function and Benefit)

The general purpose of Brufen is to provide symptomatic relief across a range of common physical responses by inhibiting the production of biological mediators. This NSAID works by temporarily interrupting the body's synthesis of prostaglandins, which are the specific chemical messengers that trigger both pain and inflammation. This foundational mechanism is clinically recognized for its effectiveness in providing quick relief from acute discomfort. A typical use scenario involves alleviating the pain and inflammation associated with common musculoskeletal aches, providing the general benefit of reducing discomfort associated with swelling, pain, and elevated body temperature.

What side effects are possible with Brufen?

Possible Side Effects and Safety Information

The official safety information for Brufen (Ibuprofen) is classified by governmental regulatory authorities based on the frequency and the physiological system affected, establishing a clear profile of potential adverse reactions.

Adverse effects are categorized by incidence, with Common reactions (affecting up to 1 in 10 people) generally involving Gastrointestinal Disorders (such as dyspepsia, nausea, and abdominal pain) and Nervous System Disorders (such as headache and dizziness). Reactions classified as Rare or Very Rare include more clinically significant events.

Serious Adverse Reactions and Safety Patterns

Regulatory documents emphasize specific serious adverse reactions associated with this pharmacological class (NSAIDs):

  • Gastrointestinal Risk: Serious events, including bleeding, ulceration, and perforation of the stomach or intestines, are officially documented.
  • Cardiovascular Risk: The medicine may be associated with an increased risk of serious arterial thrombotic events, such as myocardial infarction and stroke.

Both the risk of major gastrointestinal events and the risk of arterial thrombotic events are officially stated to increase with higher doses and longer duration of use.

Population-Specific Safety Considerations

Specific patient populations have documented safety considerations. Older adults have an increased frequency and severity of adverse reactions, particularly gastrointestinal bleeding. Furthermore, the medicine is officially contraindicated in individuals with pre-existing conditions such as severe cardiac failure, severe renal failure, or active recurrent peptic ulceration.

Overdose and Emergency Response

The official regulatory profile for Brufen overdose is defined by a spectrum of documented clinical manifestations and specific emergency actions.

Overdose may initially present with common gastrointestinal effects, including nausea, vomiting, and epigastric pain. Central nervous system (CNS) signs are also commonly documented, such as drowsiness, lethargy, tinnitus, and headache. Severe overdose can lead to life-threatening systemic outcomes, including acute renal failure, hypotension, and metabolic acidosis. Potentially fatal outcomes include convulsions and coma.

Regulatory documentation notes specific risks for certain patient groups: children are at increased risk of severe CNS toxicity, and patients with underlying hepatic or renal impairment may face greater severity of systemic effects.

Regulatory guidance requires seeking immediate medical attention for any suspected overdose, regardless of initial symptoms. Urgent help must be sought immediately if severe symptoms like convulsions, loss of consciousness, or Gastrointestinal hemorrhage are present. The official classification states that no specific antidote is known for Ibuprofen. Consequently, management is formally documented as symptomatic and supportive treatment. This necessitates hospital monitoring, including the assessment of vital signs and laboratory parameters such as renal function and serum electrolytes, as an officially described procedural step.

Therapeutic Uses of Brufen

What Brufen Treats: Main Uses and Benefits

Brufen provides supportive symptomatic relief across three major therapeutic domains. The medication is commonly used for managing both pain and inflammation associated with chronic conditions like osteoarthritis and rheumatoid arthritis, where it assists with easing stiffness and supports day-to-day comfort. It is also relevant when addressing acute and episodic discomfort, including headaches, dental pain, and the challenging symptoms of primary dysmenorrhea (menstrual pain).


“This range of uses provides support that contributes to easing the overall symptom burden.”


The medication is commonly applied in contexts involving conditions marked by increased physiological stress, specifically for reducing fever and easing general body aches linked to seasonal illnesses like the cold or flu. Indications commonly addressed include musculoskeletal aches, fever, menstrual pain, and pain from acute injury or inflammation. It offers symptomatic relief that may help patients cope more steadily with symptom fluctuations.


Quick Fact: Relief for Acute Discomfort

Symptom Category Therapeutic Context Primary Benefit
Inflammation Chronic or acute joint/tissue issues Supports symptoms that interfere with daily functioning
Fever Systemic illness (cold/flu) Eases heightened distress
Acute Pain Headache, dental, or menstrual discomfort Contributes to easing overall symptom load

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Brufen?

The eligibility for using Brufen (Ibuprofen) is strictly defined by official regulatory labeling, focusing on specific health conditions, age, and physiological states. Use is contraindicated and absolutely prohibited for several population groups.

Absolute Non-Eligibility (Contraindications)

Condition Regulatory Status
Severe Organ Failure Contraindicated (Severe hepatic, renal, or heart failure)
Active Bleeding/Ulceration Contraindicated (Active or history of recurrent peptic ulcer/hemorrhage)
NSAID Allergy/Asthma Contraindicated (Known hypersensitivity or NSAID-induced reactions)
Late Pregnancy Contraindicated (Third trimester of pregnancy)

Restricted and Conditional Use

Age-Related Use: The medicine is generally not recommended for infants under 3 months or 5 kg of weight. Older adults require the use of the lowest effective dose for the shortest duration due to increased risks. Pregnancy use is restricted to the first and second trimesters and requires caution.

Comorbidity Limitations: Individuals with mild-to-moderate renal or hepatic impairment, certain cardiovascular risks, or a history of inflammatory bowel disease must use the medicine with caution under strict limitations defined in the regulatory labeling.

What should I know about interactions with other medicines?

The official regulatory profile for Brufen defines specific constraints concerning co-administration with other medicines and substances.

Formally Contraindicated Combinations

Strict avoidance is mandated for co-administration with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including COX-2 selective inhibitors, due to the high risk of additive gastrointestinal toxicity. Ibuprofen is also contraindicated for high-dose Acetylsalicylic Acid (Aspirin) and for managing peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.

Interactions Affecting Exposure and Efficacy

Ibuprofen can officially decrease the renal clearance of certain co-administered drugs, leading to increased plasma concentrations. This pharmacokinetic effect is documented with Lithium and Methotrexate (high dose). The product may also increase the plasma levels of Cardiac Glycosides.

Co-administration with Antihypertensives (e.g., ACE inhibitors, Beta-blockers) and Diuretics may officially result in the diminution of their therapeutic effects, a consequence of pharmacodynamic interference.

Interactions Increasing Adverse Risk

A significant pharmacodynamic interaction involves the enhancement of bleeding risk when Brufen is co-administered with Anticoagulants (e.g., Warfarin), Corticosteroids, Anti-platelet Agents, and Selective Serotonin Reuptake Inhibitors (SSRIs). The concurrent use of Alcohol is also officially associated with an increased risk of serious gastrointestinal bleeding. The risk of adverse reactions, particularly fatal gastrointestinal bleeding, is officially noted to be increased in elderly patients receiving other interacting agents.

Mechanism of Action

How Brufen Works

The mechanism of action for Ibuprofen involves targeted, reversible interference with crucial enzyme systems and signaling cascades, leading to defined physiological changes across multiple systems.


Non-Selective Enzyme Inhibition

This domain covers the drug's initial action as a non-selective, reversible inhibitor of the Cyclooxygenase ( COX) enzymes ( COX-1 and COX-2). By competitively blocking these molecular targets, Ibuprofen suppresses the synthesis of all downstream prostanoids from arachidonic acid. This initial molecular event determines the primary basis of the drug's effect profile by initiating the reduction of inflammatory and pyrogenic mediators throughout the body.


Modulating Signaling and Sensory Pathways

This domain addresses the resulting physiological consequences of the enzyme block. The reduced concentration of the signaling molecule prostaglandin E2 ( PGE2) diminishes the sensitization of peripheral nociceptors, which are the pain-sensing nerve endings. Additionally, PGE2 synthesis is blocked centrally within the hypothalamus, which shifts the elevated thermoregulatory set point to a lower baseline. This combined peripheral and central action modulates heightened physiological signaling.


Mechanism Limitations (Reversible Binding)

A key characteristic of the mechanism is that the binding to the COX enzyme is reversible. This limits the duration of the inhibitory effect to the time the drug is present in sufficient concentration, contrasting with mechanisms that involve permanent, irreversible enzyme modification. This reversible mechanism results in a transient anti-platelet effect through temporary inhibition of COX-1 in platelets.

Dosage and Administration Information

Instruction Map: How to use Brufen — Administration Guidelines

This instruction map summarizes the administration rules for Brufen (Ibuprofen), detailing the principles that govern its use in clinical practice.


Administration Scope

  • Route of administration: The medicine is approved for Oral intake (e.g., tablet, suspension) and Intravenous (IV) injection in hospital settings for appropriate product forms.
  • Dosing schedule: Adult dosing ranges from a minimum of 200 mg per dose for acute symptoms, up to a maximum daily dose of 3200 mg for prescription use in chronic inflammatory conditions. Standard prescription regimens begin in the range of 1200 mg to 1800 mg daily, taken in divided administrations.
  • Timing in relation to meals (if applicable): Oral administration is generally advised to be taken with food or milk and a full glass of water to mitigate the potential for gastric irritation.
  • Preparation requirements (if applicable): Oral liquid suspensions must be shaken well prior to measurement. IV formulations require dilution and must be administered as an infusion over a minimum duration (e.g., 30 minutes for adults).
  • Age-group administration rules: Pediatric dosing is not fixed and is calculated based on the child’s body weight (mg/kg). Treatment for older adults mandates the use of the lowest effective dose for the shortest necessary duration.
  • Missed-dose rules: If a dose is forgotten, it should be taken as soon as the lapse is noted, unless the next scheduled dose is due. In this situation, the patient is instructed not to double the next dose.
  • Special procedural conditions: Certain dosage forms, such as extended-release tablets, must be swallowed whole and must not be crushed, split, or chewed.

Instruction Classifications (High-Level)

Classification Pattern
Administration method type Oral and Intravenous (IV).
Frequency pattern Two to four times daily (divided doses), with a required 4 to 6 hour interval between administrations.
Use-context constraints Administration with food/milk is a key constraint for oral forms; IV administration is restricted to the hospital setting.

Resulting Procedural Structure

Step sequence:

  • Confirm the dose and appropriate formulation for the route of administration.
  • Administer the dose with a full glass of water, and with food or milk, if appropriate.
  • Maintain the mandatory minimum time interval between doses.
  • Use is defined as short-term for acute symptoms or long-term maintenance for chronic conditions.

Connection to the overall use protocol (2–4 sentences):

The administration guidelines establish a standardized protocol centered on the required route of delivery (oral/IV), the quantity of medicine (dose range and maximum), and the timing of administration (frequency and meal relation). This structured approach mandates specific steps for preparing the medication and sets clear limits for total daily intake, ensuring use is consistent with established clinical guidelines.

Recent Clinical Evidence

Research evidence / Overview of Studies for Brufen

Evidence from Trials for Acute Pain Relief and Fever Reduction

Brufen was evaluated in numerous short-term Randomized Controlled Trials (RCTs) and subsequent Systematic Reviews in research exploring how symptoms change over time related to acute pain and fever. This research examined outcomes related to physical discomfort and outcomes related to systemic or functional imbalance. Studies was observed in a broad population, including adults and children as young as six months, where research was relevant in trials assessing short-term or episodic symptom patterns.

The studies explored outcomes related to physical discomfort and changes in body temperature. The findings describe patterns observed in the studies over the course of the initial hours after administration. For instance, in acute pain trials, research tracked patterns in the recorded use of additional pain relief, which contributes to the broader evidence landscape regarding short-term symptom patterns. Research examined changes measured during the study period related to physical discomfort.

However, the majority of this evidence is limited to single-dose or very short follow-up durations. Consequently, follow-up durations were limited; there is limited information for understanding pain or fever patterns beyond the initial acute episode. Long-term effects are not fully established.


Studies for Chronic Symptom Management

For conditions marked by functional limitations like Rheumatoid Arthritis and Osteoarthritis, the evidence structure includes longer-duration Randomized Controlled Trials and large-scale observational studies. This research examined outcomes reflecting daily functioning or activity level, as well as monitoring of local symptoms like joint swelling, in populations of adults and older adults where symptoms may vary in intensity.

These longer-term studies were conducted during periods of increased symptom activity and typically monitored patient-reported outcomes describing perceived discomfort and functional measures over periods of several weeks to months. The findings describe patterns observed in the studies related to functional measures that was observed in the studied groups over time. This evidence contributes to understanding symptom patterns in conditions presenting with cycles of stability and flare-ups.

Frequently Asked Questions (FAQ)

Common questions about Brufen (FAQ)


Q: Why is Brufen sometimes prescribed for fever and not just pain?

Brufen is classified as an analgesic (pain reliever) and an antipyretic (fever reducer). The official product information explains that the medicine's mechanism acts both in the body's tissues to reduce pain and centrally in the hypothalamus, the part of the brain responsible for regulating body temperature. By modulating this central temperature control, the medicine is used to help reduce fever.


Q: How quickly can someone expect Brufen to start working?

Clinical research and official information indicate that for standard oral forms of Brufen, the relief from discomfort typically begins within approximately 30 to 50 minutes after administration. The onset of action, however, may vary depending on the specific product formulation and individual physiology.


Q: How long does the effect of a single dose of Brufen typically last?

The duration of the medicine's activity is related to its elimination half-life, which is the time it takes for half the drug to be removed from the body. Regulatory documents describe this half-life as being in the range of approximately 1.8 to 2.2 hours. This value helps regulatory bodies establish the appropriate time intervals required between administrations.


Q: Is it true that Brufen should be taken with food?

Official administration instructions often suggest administration of oral formulations of Brufen with food, milk, or a full glass of water. This recommendation is intended to help mitigate the potential for stomach irritation or discomfort.


Q: What are the most common or mild side effects associated with Brufen?

Commonly reported reactions documented in regulatory safety information generally involve the gastrointestinal system, such as nausea, abdominal pain, and dyspepsia (indigestion). Nervous system effects, including headache and dizziness, are also frequently observed.


Q: What is the difference between prescription-strength Brufen and over-the-counter Brufen?

The distinction is based on the single dose strength and the total maximum daily dose permitted. Higher single-unit strengths of Brufen (typically 400 mg and above) are generally classified as prescription-only, while lower strengths are often available over-the-counter.


Q: Are there any known interactions between Brufen and alcohol?

Official warnings state that consuming alcohol concurrently with Brufen is associated with an increased risk of gastrointestinal bleeding. Additionally, regulatory documents note that alcohol may potentially increase central nervous system side effects such as dizziness.


Q: Why is Brufen sometimes taken to manage menstrual pain?

Regulatory documentation confirms that Brufen is indicated for the treatment of pain associated with primary dysmenorrhea (menstrual pain). Its documented ability to relieve pain and reduce inflammation makes it suitable for addressing this common complaint.


Q: Can Brufen be taken alongside antibiotics?

Official drug interaction principles do not mandate strict contraindication for all antibiotic combinations. However, regulatory documentation notes that certain antibiotics may potentially increase the risk of adverse effects on kidney function, which is a key precaution associated with Brufen.


Q: Is there a known risk of kidney problems associated with long-term use of Brufen?

Regulatory warnings state that prolonged use of Brufen, especially at high doses, is associated with an increased risk of adverse renal (kidney) effects. This risk is particularly noted for individuals who may already be susceptible to kidney issues.


Q: Does Brufen interact with commonly taken supplements like fish oil or garlic?

Official guidance advises caution regarding the co-administration of Brufen with supplements containing omega-3 fatty acids, such as fish oil. This combination may potentially increase the risk of bleeding, according to regulatory warnings.


Q: Does Brufen cause drowsiness or affect the ability to drive?

Documented undesirable effects associated with Brufen include dizziness or sleepiness. Official product documents indicate that individuals should exercise caution before driving or operating machinery until they are familiar with how the medicine affects them.


Q: Why is Brufen sometimes given to children?

Regulatory bodies have approved Brufen for use in children for specific purposes. Official documentation indicates that the medicine is used in the pediatric population for the temporary relief of mild to moderate pain and the reduction of fever.


Q: Is Brufen effective for treating headaches or migraines?

Clinical evidence summarized in regulatory reviews describes Brufen as useful for reducing the intensity of pain associated with headaches, including acute migraine attacks.


Q: Can Brufen be used for symptoms related to the common cold or flu?

The documented purpose of Brufen is the temporary relief of pain and the reduction of fever. These are key symptoms often present during a common cold or flu episode.


Q: Is it possible to be allergic to Brufen?

Yes, regulatory profiles list a known hypersensitivity or history of allergic reactions to Brufen (or other Non-Steroidal Anti-Inflammatory Drugs, NSAIDs) as an absolute contraindication for its use. This highlights the possibility of an allergic response.


Q: Why is there a warning about Brufen and dehydration?

Official warnings note that Brufen should be used with caution in individuals who are dehydrated or have reduced fluid levels. Dehydration is listed as a factor that may increase the risk of adverse effects on kidney function when taking the medicine.


Q: Does Brufen have a ceiling effect on pain relief?

Research has examined the concept of an analgesic ceiling effect, which is when increasing the dose beyond a certain point may not provide further pain relief. This concept is important because higher doses increase the documented risk of side effects without a corresponding increase in benefit.


Q: Can Brufen be used to treat swelling or inflammation from an injury?

Yes, the approved uses for Brufen include the reduction of inflammation and pain. These are the physical responses that often occur following an injury.


Q: What is the half-life of Brufen?

Pharmacokinetic data available in official documents indicates that the elimination half-life of Brufen is typically approximately 2 hours in healthy adults. This pharmacokinetic information is used to establish the required time intervals between administrations.


Q: Is Brufen a selective or non-selective inhibitor?

The medicine's mechanism is officially described as the non-selective, reversible inhibition of the cyclooxygenase (COX) enzyme system. This means it is described as targeting both major forms of the cyclooxygenase (COX) enzyme system.


Q: Is it normal to feel light-headed or dizzy after taking Brufen?

Yes, official safety information classifies both dizziness and light-headedness as documented common undesirable effects. Individuals who experience these effects should exercise caution, particularly when performing tasks that require concentration, as per general safety guidelines.


Q: What is the regulatory status of Brufen in major countries?

Brufen, containing the active ingredient Ibuprofen, is approved by major government health authorities worldwide, including the FDA and EMA. It is widely available in both over-the-counter and prescription formulations.


Q: What are the signs of a serious, but rare, skin reaction to Brufen?

Regulatory warnings document that rare, serious skin reactions may occur. These reactions may present as signs such as a rash, blistering, or peeling of the skin, potentially affecting the mouth, eyes, or genital areas.


Q: Is Brufen effective for nerve pain?

Brufen is primarily indicated for pain related to inflammation. Official evidence suggests that its use for neuropathic (nerve) pain is typically considered only where inflammation is known to be a contributing component of the pain experience.


Q: Is there any difference in how different dosage forms (e.g., liquid vs. tablet) of Brufen work?

Research indicates that dosage forms designed for rapid absorption, such as liquid suspensions or specific capsule types, may result in quicker drug absorption. This leads to a faster time to reach peak concentration in the blood compared to standard tablet forms.


Q: Can Brufen be used on an empty stomach?

Official guidance often advises taking the medicine with food or milk to help prevent stomach irritation. While low-dose oral formulations may be taken without food, this should be done with awareness of the potential for gastrointestinal upset.

How should Brufen be stored and disposed of?

How to Store and Dispose of Brufen?

Regulatory documents define specific requirements for storing and disposing of Brufen (ibuprofen) to ensure product stability and environmental safety.

Official Storage Conditions

Brufen is generally required to be stored at controlled room temperature, typically 20 C to 25 C, and must be protected from excessive heat, moisture, and light. The medicine must be kept in its original container and stored out of the sight and reach of children.

Official Disposal Rules

Disposal Requirement Classification
Do not dispose of via household waste or wastewater. Risk to the environment
Return unused product to a pharmacy collection point. Adherence to local regulations

All unused or expired Brufen must be disposed of in accordance with local pharmaceutical waste requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Brufen found in:

A-Z Index: